Future Perspectives for Biopharma Quality: A Focus on People, Process, and Proactive Risk Mitigation

Custom content for Samsung Biologics by studioID

 WEBINAR ON DEMAND
Duration: 1 hour


Developing and manufacturing lifesaving therapies is a multi-faceted and complex process that is highly regulated. Supplying a qualified product to patients requires significant expertise, collaboration, and risk mitigation.

For this reason, it’s critical for biopharmaceutical insiders to harness the power of the latest technologies to navigate the necessary steps. But what are the best practices for optimizing quality control, both today and in the future?

This webinar features a panel of industry experts who will share their depth of experience and discuss the most recent trends in biopharmaceutical quality and compliance. It will teach you:

  • The elements that define biopharmaceutical quality
  • How to navigate the regulatory and compliance landscape
  • The new technologies and processes that are shaping the current and future industry

The future of biopharmaceutical quality starts now, so don’t miss your chance to stay ahead of the curve.

 

SPEAKERS  

Keith Ellis
VP, Corporate QA
Samsung Biologics


Calvin Kim
Head of Quality Systems & Validation
Samsung Biologics

 

WATCH NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2021 Industry Dive | Privacy Policy | Terms of Use